http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101703769-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab577eeec79692cd6696b72706467ddc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 |
| filingDate | 2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_042debd57e062fc9a7d35bf718ddc02b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dfde08c99b30351bf4e4ac2b9335001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab76f15575cdd710a83a58939f385251 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dec90b3bcc006b800e5e4e91caf4c76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fda5fd50b02be8d08378925df9c7eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6605220e8d5635351ae05e09a948b4ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3a8a0a0da9eed782e6901ab00af0877 |
| publicationDate | 2013-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101703769-B |
| titleOfInvention | Novel tetravalent inactivated vaccine for streptococcus suis disease |
| abstract | The invention relates to a novel tetravalent inactivated vaccine for streptococcus suis disease, which is prepared from a Lancefield group C streptococcus equi zooepidemicus C55138 antigen, a Lancefield group D streptococcus C55914 antigen, a Lancefield group E streptococcus C55949 antigen and a streptococcus suis type 2 HA9801 antigen by the steps of strain reproduction, bacterial liquid cultivation, pure inspection, live bacteria counting, inactivation, inactivation inspection, sedimentation and concentration, toxin removal, vaccine preparation by mixing, asepsis inspection of the vaccine, potency inspection and subpackaging. The novel tetravalent inactivated vaccine for the streptococcus suis disease can take precautions against four streptococcus suis diseases caused by Lancefield group C streptococcus, Lancefield group D streptococcus, Lancefield group E streptococcus and streptococcus suis type 2 through one-time vaccination, and has wide application prospect. |
| priorityDate | 2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.